Evidence map›Paper›PMID 39180133›Full record

ArticleOrphanet journal of rare diseases2024

Characterization of pathogenic genetic variants in Russian patients with primary ciliary dyskinesia using gene panel sequencing and transcript analysis.

Anna Zlotina, Svetlana Barashkova, Sergey Zhuk, Rostislav Skitchenko, Dmitrii Usoltsev, Polina Sokolnikova, Mykyta Artomov, Svetlana Alekseenko, Tatiana Simanova, Maria Goloborodko and 2 more

Abstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Anna ZlotinaAlmazov National Medical Research Centre, Saint-Petersburg, Russia, 197341. anna-zlotina@yandex.ru.ORCID 0000-0002-2029-1197
Svetlana BarashkovaAlmazov National Medical Research Centre, Saint-Petersburg, Russia, 197341.
Sergey ZhukAlmazov National Medical Research Centre, Saint-Petersburg, Russia, 197341.
Rostislav SkitchenkoAlmazov National Medical Research Centre, Saint-Petersburg, Russia, 197341.
Dmitrii UsoltsevInstitute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH, 43205, USA.
Polina SokolnikovaAlmazov National Medical Research Centre, Saint-Petersburg, Russia, 197341.
Mykyta ArtomovInstitute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH, 43205, USA.
Svetlana AlekseenkoK.A. Raukhfus Children's City Multidisciplinary Clinical Center for High Medical Technologies, Saint-Petersburg, Russia, 191036.
Tatiana SimanovaRepublican Children's Clinical Hospital of the Ministry of Health of the Udmurt Republic, Izhevsk, Russia, 426009.
Maria GoloborodkoK.A. Raukhfus Children's City Multidisciplinary Clinical Center for High Medical Technologies, Saint-Petersburg, Russia, 191036.
Olga BerlevaK.A. Raukhfus Children's City Multidisciplinary Clinical Center for High Medical Technologies, Saint-Petersburg, Russia, 191036.
Anna KostarevaAlmazov National Medical Research Centre, Saint-Petersburg, Russia, 197341.

Funding

Ministry of Science and Higher Education of the Russian Federation 075-15-2022-301
6 · The paper itself

Abstract

backgroundPrimary ciliary dyskinesia (PCD) is a group of rare genetically heterogeneous disorders caused by defective cilia and flagella motility. The clinical phenotype of PCD patients commonly includes chronic oto-sino-pulmonary disease, infertility, and, in about half of cases, laterality defects due to randomization of left-right body asymmetry. To date, pathogenic variants in more than 50 genes responsible for motile cilia structure and assembly have been reported in such patients. While multiple population-specific mutations have been described in PCD cohorts from different countries, the data on genetic spectrum of PCD in Russian population are still extremely limited.

resultsThe present study provides a comprehensive clinical and genetic characterization of 21 Russian families with PCD living in various country regions. Anomalies of ciliary beating in patients` respiratory epithelial cells were confirmed by high-speed video microscopy. In the most cases, custom-designed panel sequencing allowed to uncover causative variants in well-known or rarely mentioned PCD-related genes, including DNAH5, DNAH11, CFAP300, LRRC6, ZMYND10, CCDC103, HYDIN, ODAD4, DNAL1, and OFD1. The variations comprised common mutations, as well as novel genetic variants, some of which probably specific for Russian patients. Additional targeted analysis of mRNA transcripts from ciliated cells enabled us to specify functional effects of newly identified genetic variants in DNAH5 (c.2052+3G>T, c.3599-2A>G), HYDIN (c.10949-2A>G, c.1797C>G), and ZMYND10 (c.510+1G>C) on splicing process. In particular, the splice site variant c.2052+3G>T, detected in four unrelated families, resulted in skipping of exon 14 in DNAH5 transcripts and, according to haplotype analysis of affected probands, was proposed as an ancestral founder mutation in Udmurt population.

conclusionsThe reported data provide a vital insight into genetic background of primary ciliary dyskinesia in the Russian population. The findings clearly illustrate the utility of gene panel sequencing coupled with transcriptional analysis in identification and clinical interpretation of novel genetic variants.

Indexed as

MutationAdolescentAdultAxonemal DyneinsChildChild, PreschoolCiliaCiliary Motility DisordersFemaleHumansKartagener SyndromeMaleRussiaAxonemal DyneinsDNAH5Founder mutationGene-panel sequencingHYDINPrimary ciliary dyskinesiaRussian populationSplice site variantsTranscript analysisZMYND10

Identifiers

PMID39180133
PMCPMC11344339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.